Therapy via targeted delivery of nanoscale particles using L6 antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040156846A1
SERIAL NO

10360578

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for treating cells, diseased tissue, pathogens, or other undesirable matter involve the administration of a bioprobe (energy susceptive materials that are attached to the target-specific ligand chimeric L6 antibody) to a patient's body, body part, tissue, or body fluid (such as blood, blood plasma, or blood serum). An energy source provides energy to the bioprobe so as to destroy, rupture, or inactivate the target. Various energy forms, such as AMF, microwave, acoustic, or a combination thereof, created via a variety of mechanisms, may be used. The disclosed methods may be useful in the treatment of a variety of indications, including but not limited to, cancer of any type, such as bone marrow, lung, vascular, neuro, colon, ovarian, breast and prostate cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRITON BIOSYSTEMS INC200 TURNPIKE ROAD CHELMSFORD MA 01824

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Daum, Wolfgang Groton, MA 180 7806
DeNardo, Gerald El Macerco, CA 4 100
Ellis-Busby, Diane Lancaster, MA 8 180
Foreman, Alan Epping, NH 2 48
Gwost, Douglas U Shoreview, MN 6 281
Handy, Erik Schroeder Arlington, MA 3 225
Ivkov, Robert Marblehead, MA 14 726

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation